Authors: Hanks, GE Hanlon, AL Pinover, WH Horwitz, EM Price, RA Schultheiss, T

Citation: Ge. Hanks et al., Dose selection for prostate cancer patients based on dose comparison and dose response studies, INT J RAD O, 46(4), 2000, pp. 823-832

Authors: Wiseman, GA White, CA Stabin, M Dunn, WL Erwin, W Dahlbom, M Raubitschek, A Karvelis, K Schultheiss, T Witzig, TE Belanger, R Spies, S Silverman, DHS Berlfein, JR Ding, E Grillo-Lopezs, AJ

Citation: Ga. Wiseman et al., Phase I/II Y-90-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma, EUR J NUCL, 27(7), 2000, pp. 766-777

Authors: Herbert, D Ovadia, J Schultheiss, T

Citation: D. Herbert et al., Obituary: Lionel Cohen, MD, Ph.D-1918-1999, MED PHYS, 26(11), 1999, pp. 2219-2219